Since is concave up when is increasing and concave down when is decreasing, then is concave up on the intervals and , and concave down on the interval
Moreover, protein activity loss (e.g., Concanavalin A, GOx) during storage and administration is another issue 36, 37 , which significantly retards the long-term responsive capacity of the system
While existing Medication-Assisted Treatments (MAT) like buprenorphine and naltrexone remain vital tools, GLP-1 agonists represent an exciting frontier in expanding treatment options
HSA-funded GLP-1 therapy requires ongoing provider supervision including baseline labs, periodic metabolic monitoring, and dose adjustments
As the national conversation around GLP-1 therapy continues to evolve, Ivim remains focused on data-driven outcomes and delivering care that adapts to each patients unique needs